Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.

Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan. Department of Food Science, Rutgers University, New Brunswick, NJ, USA. Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan.

BioFactors (Oxford, England). 2018;(1):26-35

Abstract

Epigenetic mechanisms are essential in regulating normal cellular functions and play an important role during the disease developmental stages. However, aberrant epigenetic mechanisms may lead to pathological consequences such as cancer, neurological disorders, bone and skeletal diseases, cardiovascular dysfunction, and metabolic syndrome. The molecular mechanisms of epigenetic modification include DNA methylation, histone modification (acetylation, methylation and phosphorylation), and microRNAs (miRNAs). Unlike genetic modifications, epigenetic states of genes are reversible and can be altered by certain intrinsic and extrinsic factors. In the past few decades, accumulated evidence shows that dietary phytochemicals with chemopreventive effects are also potent epigenetic regulators. Resveratrol and pterostilbene are stilbenoids, which have been reported to have anti-cancer, anti-inflammatory, anti-lipid, and anti-diabetic properties. Stilbenoids are also reported to improve cardiovascular disease. By altering DNA methylation and histone modification or by modulating miRNA expression, resveratrol, and pterostilbene become potent epigenetic modifiers. In this review, we summarize these studies and underlying mechanisms of resveratrol and pterostilbene and their influence on epigenetic mechanisms. © 2017 BioFactors, 44(1):26-35, 2018.

Methodological quality

Publication Type : Review

Metadata